DAUNORUBICIN for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 31 adverse event reports in the FDA FAERS database where DAUNORUBICIN was used for Neoplasm malignant.
Most Reported Side Effects for DAUNORUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 1,311 | 13.3% | 168 | 683 |
| Pyrexia | 645 | 6.6% | 117 | 419 |
| Neutropenia | 631 | 6.4% | 95 | 300 |
| Sepsis | 515 | 5.2% | 207 | 298 |
| Off label use | 462 | 4.7% | 132 | 149 |
| Pneumonia | 402 | 4.1% | 213 | 176 |
| Bacterial infection | 400 | 4.1% | 272 | 102 |
| Drug ineffective | 375 | 3.8% | 137 | 133 |
| Septic shock | 363 | 3.7% | 174 | 225 |
| Thrombocytopenia | 347 | 3.5% | 85 | 152 |
| Pancytopenia | 345 | 3.5% | 89 | 135 |
| Clostridium difficile colitis | 331 | 3.4% | 218 | 116 |
| Myelosuppression | 319 | 3.2% | 25 | 106 |
| Hypotension | 298 | 3.0% | 97 | 260 |
| Product use in unapproved indication | 280 | 2.8% | 80 | 116 |
Other Indications for DAUNORUBICIN
Acute lymphocytic leukaemia (3,111)
Acute myeloid leukaemia (2,423)
Product used for unknown indication (449)
T-cell type acute leukaemia (367)
B precursor type acute leukaemia (274)
Chemotherapy (219)
B-cell type acute leukaemia (212)
Precursor t-lymphoblastic lymphoma/leukaemia (211)
Non-hodgkin's lymphoma (141)
Acute promyelocytic leukaemia (137)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)